Essential Thrombocytosis
4 clinical trials · Condition
◉ Watch Essential Thrombocytosis
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies (NCT02158858) | Constellation Pharmaceuticals | 2014-07-16 |
| Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis (NCT00586651) | Cephalon | 2007-12-01 |
| Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders (NCT00433862) | National Institutes of Health Clinical Center (CC) | 2007-02-06 |
Track Essential Thrombocytosis automatically
Every clearance here is in the API, with alerts when new ones post.